YS Biopharma Co Ltd (YS)
0.80
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.8085
+0.01
(+1.06%)
After-Hours: 20:00
YS Biopharma Cash and Short Term Investments (Quarterly): 35.62M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 35.62M |
| June 30, 2023 | 13.06M |
| Date | Value |
|---|---|
| September 30, 2022 | 31.82M |
| March 31, 2022 | 42.64M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.06M
Minimum
Jun 2023
42.64M
Maximum
Mar 2022
30.79M
Average
33.72M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 11.07B |
| CASI Pharmaceuticals Inc | 30.77M |
| Zai Lab Ltd | 806.45M |
| I-MAB | 406.06M |
| Gracell Biotechnologies Inc (DELISTED) | 234.08M |